E74.810 ICD-10-CM Code: Glucose transporter protein type 1 deficiency
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Endocrine, nutritional and metabolic diseases (E00-E89) / Metabolic disorders (E70-E88)
E74.810
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceGlucose transporter protein type 1 deficiency
This is a rare genetic disorder where the body cannot properly transport glucose (sugar) into the brain due to a defective protein. This causes low blood sugar levels in the brain, leading to seizures, developmental delays, and movement problems.

Buddy Insight
Glucose transporter protein type 1 (GLUT1) deficiency syndrome is a genetic neurometabolic disorder where impaired glucose transport across the blood-brain barrier results in cerebral energy failure.
CMS-HCC V28
00
RAF 0
CMS-HCC V24
MappedHCC 23
RAF 0.194
ACA/HHS
00
RAF 0
ESRD/PACE
MappedHCC 23
RAF 0.0
RXHCC
MappedHCC 43
RAF 0.0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
Official- De Vivo syndrome
- Glucose transport defect, blood-brain barrier
- Glut1 deficiency
- GLUT1 deficiency syndrome 1, infantile onset
- GLUT1 deficiency syndrome 2, childhood onset
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for E74.810 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for E74.810 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for E74.810 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for E74.810 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for E74.810 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for E74.810 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is E74.810 an HCC code?
Yes. E74.810 maps to Other Significant Endocrine and Metabolic Disorders under the V24 model but is not retained in V28.
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work E74.810 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for E74.810
For E74.810to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed E74.810 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
E74.810 is the ICD-10-CM diagnosis code for glucose transporter protein type 1 deficiency. This is a rare genetic disorder where the body cannot properly transport glucose (sugar) into the brain due to a defective protein. This causes low blood sugar levels in the brain, leading to seizures, developmental delays, and movement problems. E74.810 sits in the ICD-10-CM chapter for endocrine, nutritional and metabolic diseases (e00-e89), within the section covering metabolic disorders (e70-e88).
Under the older CMS-HCC V24 model, E74.810 maps to Other Significant Endocrine and Metabolic Disorders (HCC 23) with a community, non-dual, aged base RAF weight of 0.194. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
This is a specific metabolic disorder code that requires documentation of the glucose transporter protein type 1 deficiency diagnosis; do not use more general glucose metabolism codes. Because E74.810 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for E74.810 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This is a specific metabolic disorder code that requires documentation of the glucose transporter protein type 1 deficiency diagnosis; do not use more general glucose metabolism codes
- •This condition is often associated with seizures and neurological symptoms, so review documentation for additional codes related to epilepsy or neurological manifestations that should be coded separately
Clinical Significance
Glucose transporter protein type 1 (GLUT1) deficiency syndrome is a genetic neurometabolic disorder where impaired glucose transport across the blood-brain barrier results in cerebral energy failure. Patients develop epilepsy (often drug-resistant), developmental delay, acquired microcephaly, and complex movement disorders. The ketogenic diet is the primary treatment, providing ketone bodies as an alternative brain fuel source.
Documentation Requirements
- ✓Confirmed diagnosis of GLUT1 deficiency syndrome
- ✓Low cerebrospinal fluid glucose with normal blood glucose (hypoglycorrhachia)
- ✓SLC2A1 gene mutation analysis results
- ✓Documentation of seizure type and frequency
- ✓Ketogenic diet implementation and adherence status
- ✓Neurological assessment including developmental milestones and movement disorder evaluation
Commonly Confused Codes
- •E74.818: Other disorders of glucose transport: for glucose transport disorders other than GLUT1
- •E74.819: Disorders of glucose transport, unspecified: use only when specific transport disorder is not identified
- •G40.89: Other seizures: seizures are a manifestation of GLUT1 deficiency
- •E16.2: Hypoglycemia, unspecified: blood glucose is normal in GLUT1 deficiency; the low glucose is in CSF only
- •E74.9: Disorder of carbohydrate metabolism, unspecified: much less specific